[1]全国结核病流行病学抽样调查技术指导组.第四次全国流行病学抽样调查报告.中华结核和呼吸杂志, 2002,25(1):3-7.[2]Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science,1999,284(5419):1520-1523.[3]Millington KA, Fortune SM, Low J, et al. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A, 2011,108(14):5730-5735.[4]Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive va-lue of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis,2012,12(1):45-55.[5]Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep,2010,59(RR-5):1-25.[6]中华医学会结核病学分会.肺结核诊断和治疗指南.中华结核和呼吸杂志, 2001,24(2):70-74.[7]Ferrara G, Losi M, D’Amico R,et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet, 2006,367(9519):1328-1334.[8]Hill PC, Jackson-Sillah D, Fox A, et al. ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of Mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia. J Clin Microbiol, 2005, 43(5): 2070-2074.[9]刘菲, 张宗德,杜凤娇,等.酶联免疫斑点检测斑点形成细胞在结核潜伏感染诊断中的价值. 中华检验医学杂志,2009,32(8):900-904.[10]Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest, 2010,137(4):952-968.[11]Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive va-lue of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.Lancet Infect Dis,2012,12(1):45-55.[12]Richeldi L, Losi M, D’Amico R, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest, 2009,136(1):198-204.[13]Walsh MC,Camerlin AJ,Miles R, et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis,2011,15(2):179-184,i-iii. |